Bill denial for the prescription drug price cap called ‘a major setback’ for diabetics in the state

  • IHeartBadCode@kbin.social
    link
    fedilink
    arrow-up
    21
    ·
    1 year ago

    Just an FYI. The CalRx insulin is being produced by Civica Rx. They will be producing three insulins for the program. Glargie, Lispro, and Aspart. These are generic biologics that are interchangeable with Lantus (long-acting), Humalog (fact-acting), and Novolog (instant). Additionally, for the products where this makes sense, products will be available in vial and autoinjector formats. The $30 price is that of the vials and $55 for a box of five autoinjectors.

    So main take aways should be CalRx will be producing analogs and will be providing a wide band of types for different needs.

    • squiblet@kbin.social
      link
      fedilink
      arrow-up
      1
      ·
      1 year ago

      Humalog (lispro) is approximately the same as Novolog (aspart). There are rapid actings, they are Fiasp and Lyumjev.